NDC 50474-925 - Lortab

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50474-925
Package NDCs from labels
50474-925-01, 50474-925-50
Manufacturer
UCB PHARMA, INC.
Effective date
2006-10-20
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Lortab - UCB PHARMA, INC.UCB PHARMA, INC.2006-10-20Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50474-925-01Lortab100 in 1 BOTTLE, PLASTICTABLET1001
50474-925-50Lortab500 in 1 BOTTLE, PLASTICTABLET5001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50474-925LORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]12 package rows20061201_1FB18A80-8EF0-4BCE-BB0D-9A86851C5206.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
Hydrocodone bitartrateACTIVE INGREDIENTNO70W886KKLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
HydrocodoneACTIVE MOIETY6YKS4Y3WQ7LORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
CROSPOVIDONEINACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
FD & C RED #3INACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
MICROCRYSTALLINE CELLULOSEINACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
POVIDONEINACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
PREGELATINIZED STARCHINACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
SUCROSEINACTIVE INGREDIENTC151H8M554LORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1
SUGAR SPHERESINACTIVE INGREDIENTLORTAB (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [UCB PHARMA, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1FB18A80-8EF0-4BCE-BB0D-9A86851C52061FB18A80-8EF0-4BCE-BB0D-9A86851C52062006-10-20Warnings, Adverse reactionsExact identifier
spl id: 1FB18A80-8EF0-4BCE-BB0D-9A86851C5206
spl set id: 1FB18A80-8EF0-4BCE-BB0D-9A86851C5206

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.